Siba El Hussein, MD(@SibaElHussein) 's Twitter Profile Photo

Primary large B-cell lymphoma of the CNS: Cyclin-D1 highlights endothelial cells in brain tissue, however its pattern of expression could be misinterpreted as positivity in neoplastic cells. Comparison to MUM1 & PAX5 is helpful to avoid this pitfall

Primary large B-cell lymphoma of the CNS: Cyclin-D1 highlights endothelial cells in brain tissue, however its pattern of expression could be  misinterpreted as positivity in neoplastic cells. Comparison to MUM1 & PAX5 is helpful to avoid this pitfall #hemepath #lymsm #PathX
account_circle
Michael Dickinson(@mike_dickinson1) 's Twitter Profile Photo

Great to see our consensus guidelines on CD20x3 safety management in a nice PDF @bloodjournal bit.ly/3SvFfhl. Hopefully a useful resource for the roll out of these potent drugs

Great to see our consensus guidelines on CD20x3 #bispecific safety management in a nice PDF @bloodjournal bit.ly/3SvFfhl.  Hopefully a useful resource for the roll out of these potent drugs #lymsm #glofitamab #Epcoritamab #mosunetuzumab
account_circle
Taylor Lab UM(@TaylorJ_MD) 's Twitter Profile Photo

Excited to host Dr. Todd Druley Todd E. Druley, M.D., Ph.D. for our Sylvester Comprehensive Cancer Center TCO Seminar today! We had a great scientific conversation over dinner last night and his talk will feature exciting new single cell data from the Mission Bio Tapestri!

Excited to host Dr. Todd Druley @DruleyMB_CMO for our @SylvesterCancer TCO Seminar today! We had a great scientific conversation over dinner last night and his talk will feature exciting new single cell data from the @MissionBio Tapestri! #leusm #mmsm #lymsm #CHIPsm #cancer
account_circle
Ryan Hughes(@hughrt7) 's Twitter Profile Photo

In a combined analysis of reconstructed data from two modern trials +\- consolidative RT ☢️ for pts with advanced Hodgkin lymphoma with initial bulk after CR to ABVD, we found no PFS benefit to ☢️

A collab!

doi.org/10.1016/j.adro…

In a combined analysis of reconstructed data from two modern trials +\- consolidative RT ☢️ for pts with advanced Hodgkin lymphoma #lymsm with initial bulk after CR to ABVD, we found no PFS benefit to ☢️ 

A #NorthCarolina #Tennessee #radonc collab!

doi.org/10.1016/j.adro…
account_circle
Michael Dickinson(@mike_dickinson1) 's Twitter Profile Photo

First trial of BTKi+CART in MCL… Thanks @liapalomba & Dr Boardman in @bloodjournal for commentary on our @petermaccc sponsored trial bit.ly/3TaGxhP led by @adrianminson as part of his PhD. Thx to big team of collaborators. @lymsm

First trial of BTKi+CART in MCL… Thanks @liapalomba & Dr Boardman in @bloodjournal for commentary on our  @petermaccc sponsored trial bit.ly/3TaGxhP led by @adrianminson as part of his PhD. Thx to big team of collaborators. @lymsm
account_circle
Ryan D Morin(@morinryan) 's Twitter Profile Photo

Our latest review on DLBCL in Seminars in Hematology. This was championed by Dr. Laura Hilton.
tinyurl.com/4kwpbp27
Here's my personal favourite figure:

Our latest review on DLBCL in Seminars in Hematology. This was championed by Dr. Laura Hilton.  #lymsm  
tinyurl.com/4kwpbp27
Here's my personal favourite figure:
account_circle
Dr. Avinash Dinmohamed(@ADinmohamed) 's Twitter Profile Photo

I've observed that there seems to be a rise in virtual meetings lately. I was wondering if you had any thoughts on this. Perhaps, in some instances, a brief and well-crafted email could serve the purpose just as effectively. Would you agree?

account_circle
Joshua Fein(@joshuaafein) 's Twitter Profile Photo

Stop by poster 487 this evening to discuss CAR-T for treatment of patients with T-cell Histiocyte Rich Large B-Cell Lymphoma!
TL/DR: not a panacea (as in all LBCL) but there *is* a proportion with response. *¿would this subset benefit from adding PD1i?*

#Tandem24 #lymsm #Cartrx Stop by poster 487 this evening to discuss CAR-T for treatment of patients with T-cell Histiocyte Rich Large B-Cell Lymphoma! 
TL/DR: not a panacea (as in all LBCL) but there *is* a proportion with response. *¿would this subset benefit from adding PD1i?*
account_circle
Graham Collins(@graham74GC) 's Twitter Profile Photo

vandtved et al - pulmonary disease in Hodgkin lymphoma survivors.
• Danish database analysis
• 1474 pts treated 2000-2018
• 10y cum risk 7.4% (vs 2.9%)
• interstitial lung disease & COPD
Substantial burden of pulm disease in these pts.

onlinelibrary.wiley.com/doi/10.1111/bj…

account_circle
Tanaya Shree(@tanaya_shree) 's Twitter Profile Photo

Overheated but excited to be , to see new science and old friends, and to chat with anyone interested in joining our growing group focused on translational cancer immunology research in lymphoma OHSU Knight Cancer Institute in beautiful Portland!

Overheated but excited to be #AACR2023, to see new science and old friends, and to chat with anyone interested in joining our growing group focused on translational cancer immunology research in lymphoma @OHSUKnight in beautiful Portland! #lymsm #lymphoma #cancer #immunology
account_circle
Siba El Hussein, MD(@SibaElHussein) 's Twitter Profile Photo

Relapsed DLBCL with unusual spindle-cell morphology, reminiscent of follicular dendritic cell sarcoma (FDCS), with diffuse aberrant expression of FDC markers CD21 and CD23

Relapsed DLBCL with unusual spindle-cell morphology, reminiscent of follicular dendritic cell sarcoma (FDCS), with diffuse aberrant expression of FDC markers CD21 and CD23 #hemepath #lymsm #surgpath #pathtwitter #pathX #MedTwitter #MedX #MedEd
account_circle
Shonali Midha, M.D.(@ShoMidha) 's Twitter Profile Photo

Come join us at the outcomes session in lymphoid disorders - exciting updates on CAR-T, associated toxicities and staging in lymphoma and myeloma! Mazie Tsang, MD, MAS, MS

#ASH23 Come join us at the outcomes session in lymphoid disorders - exciting updates on CAR-T, associated toxicities and staging in lymphoma and myeloma! @MazieTsangMD #lymsm #mmsm
account_circle
Lymphoma Hub(@lymphomahub) 's Twitter Profile Photo

🚨 New account alert! 🚨

We now have an Instagram account: @lymphoma_hub

Follow us and keep an eye out for all the exciting content coming soon!

🚨 New account alert! 🚨

We now have an Instagram account: @lymphoma_hub

Follow us and keep an eye out for all the exciting content coming soon!

#lymphoma #lymsm #ChronicLymphocyticLeukemia #MedNews #MedEducation
account_circle
Blood Cancer Talks(@BloodCancerTalk) 's Twitter Profile Photo

Tune in to our lymphoma/CLL recap with Toby Eyre! We delved into key abstracts, from the phase 3 SYMPATICO trial in Mantle Cell Lymphoma to insights on Smart Stop and Mosun-Pola in DLBCL!
Eddie Cliff


tinyurl.com/5ymhz23j

account_circle